Fischer L, Jiang L, Durig J, Schmidt C, et al. The addition of bortezomib to rituximab, high-dose cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma-a randomized, open-label phase III trial of the European mantle cell lymphoma network. Leukemia 2024 Apr 27. doi: 10.1038/s41375-024-02254.
PMID: 38678093